Takeda gives Sun Pharma, Cipla rights to commercialize gastro drug in India

Japan's Takeda Pharmaceutical (4502.T) gave India's Sun Pharmaceutical (SUN.NS) and Cipla (CIPL.NS) the rights to commercialize gastrointestinal drug Vonoprazan in the country.